Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Interest & Investment Income for 7 consecutive years, with $445000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 42.58% year-over-year to $445000.0; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (down 41.18% YoY), and the FY2025 full-year result was $2.8 million, down 43.06% from the prior year.
• Interest & Investment Income eased to $445000.0 in Q2 2026 per TMCI's latest filing, from $501000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.0 million in Q2 2023 and bottomed at $9000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $924388.9 across 5 years, with a median of $808000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 16333.33% in 2023, then slumped 47.4% in 2024.
• Over 5 years, Interest & Investment Income stood at $753000.0 in 2022, then jumped by 126.96% to $1.7 million in 2023, then tumbled by 47.4% to $899000.0 in 2024, then plunged by 41.38% to $527000.0 in 2025, then fell by 15.56% to $445000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $445000.0, $501000.0, and $527000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.